Received May 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | N/A | 3052736 | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | N/A | U8855CA | IM / LA |
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | N/A | Z009681 | IM / LA |
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | E75E5 | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 4YA34 | IM / RA |
Patient's caregiver came in several months after the vaccine was administered (Administered on 09/30, and was reported today). States that the patient's entire left arm and hand (vaccines were administered in the left deltoid) swelled up so badly that she could not move them. Once the swelling slowly subsided, the patient had a red rash which was hot to the touch. After the rash went away, the patient had nerve pain and was still unable to use her left hand. Patient has subsequently see her provider and was treated with meloxicam and gabapentin. Patient is currently following up with a neurologist and had an MRI to rule out other conditions.
Unknown
Unknown
Escitalopram 20 mg, Ipratropium/Albuterol nebulizer solution
None
Patient had an MRI